These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 38017087)

  • 21. Blood pressure in relation to the renin-angiotensin-aldosterone system.
    Ljungman S; Aurell M; Hartford M; Wikstrand J; Berglund G
    Acta Med Scand; 1982; 211(5):351-60. PubMed ID: 7051760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low Response of Renin-Angiotensin System to Sodium Intake Intervention in Chinese Hypertensive Patients.
    Feng W; Cai Q; Yuan W; Liu Y; Bardeesi ASA; Wang J; Chen J; Huang H
    Medicine (Baltimore); 2016 Feb; 95(6):e2602. PubMed ID: 26871780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial.
    Coulson TG; Miles LF; Zarbock A; Burrell LM; Patel SK; von Groote T; Pilcher D; Weinberg L; Landoni G; Bellomo R
    Br J Anaesth; 2023 Oct; 131(4):664-672. PubMed ID: 37481435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of potassium supplementation on plasma aldosterone: a systematic review and meta-analysis in humans.
    McNally RJ; Farukh B; Chowienczyk PJ; Faconti L
    J Hypertens; 2024 Sep; 42(9):1581-1589. PubMed ID: 38780173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at rest and during submaximal exercise in patients with congestive heart failure.
    Kinugawa T; Ogino K; Kitamura H; Saitoh M; Omodani H; Osaki S; Hisatome I; Miyakoda H
    Am J Med Sci; 1996 Sep; 312(3):110-7. PubMed ID: 8783676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between urinary sodium excretion and serum aldosterone in patients with diabetes in the presence and absence of modifiers of the renin-angiotensin-aldosterone system.
    Libianto R; Jerums G; Lam Q; Chen A; Baqar S; Pyrlis F; Macisaac RJ; Moran J; Ekinci EI
    Clin Sci (Lond); 2014 Jan; 126(2):147-54. PubMed ID: 23875766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Responses of plasma catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide to exercise in patients with essential hypertension.
    Kinugawa T; Endo A; Kato M; Kato T; Ahmmed GU; Omodani H; Osaki S; Ogino K; Hisatome I; Miyakoda H; Fujimoto Y; Yoshida A; Shigemasa C
    Cardiology; 1997; 88(3):238-45. PubMed ID: 9129844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin II on arterial pressure, renin and aldosterone during exercise.
    Fagard R; Lijnen P; Amery A
    Eur J Appl Physiol Occup Physiol; 1985; 54(3):254-61. PubMed ID: 3905392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
    Rao MS
    J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of increased potassium intake on the renin-angiotensin-aldosterone system and subcutaneous resistance arteries: a randomized crossover study.
    Dreier R; Abdolalizadeh B; Asferg CL; Hölmich LR; Buus NH; Forman JL; Andersen UB; Egfjord M; Sheykhzade M; Jeppesen JL
    Nephrol Dial Transplant; 2020 Jun; ():. PubMed ID: 32596729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood pressure regulation on low and high sodium diets in normotensive members of normotensive or hypertensive families.
    Pusterla C; Beretta-Piccoli C; Städler P; Weidmann P; Favre L; Vallotton M
    J Hypertens Suppl; 1986 Dec; 4(6):S310-3. PubMed ID: 3475419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transdermal nitroglycerin efficacy in patients with chronic stable angina pectoris as related to sympathetic and renin-angiotensin-aldosterone activity.
    Muiesan ML; Agabiti-Rosei E; Romanelli G; Beschi M; Castellano M; Cefis M; Cerri B; Pollavini G; Muiesan G
    Eur Heart J; 1992 Jan; 13(1):15-21. PubMed ID: 1577025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aldosterone and renin in relation to surrogate measures of sympathetic activity: the SABPA study.
    Gafane-Matemane LF; van Rooyen JM; Schutte R; Schutte AE
    Cardiovasc J Afr; 2019 Jan/Feb 23; 30(1):34-40. PubMed ID: 30720841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Catecholamines, renin-angiotensin-aldosterone, and cardiovascular response during exercise following acute and long-term calcium antagonism with felodipine in essential hypertension.
    Katzman PL; Hulthén UL; Hökfelt B
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):439-44. PubMed ID: 2444797
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Associations of central and peripheral blood pressure with the renin-angiotensin-aldosterone system in healthy young adults: the African-PREDICT study.
    Gafane-Matemane LF; Mokae NL; Breet Y; Poglitsch M; Schutte AE
    Hypertens Res; 2021 Apr; 44(4):435-445. PubMed ID: 33122821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of dual vs single renin-angiotensin-aldosterone system blockade in chronic kidney disease: An updated meta-analysis of randomized controlled trials.
    Zhao M; Qu H; Wang R; Yu Y; Chang M; Ma S; Zhang H; Wang Y; Zhang Y
    Medicine (Baltimore); 2021 Sep; 100(35):e26544. PubMed ID: 34477114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the renin-angiotensin-aldosterone system on the cardiovascular system during 20-days bed rest.
    Haruna Y; Bonde-Petersen F; Takenaka K; Suzuki Y; Kawakubo K; Gunji A
    J Gravit Physiol; 1997 Jan; 4(1):S62-8. PubMed ID: 11541179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.